Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Casma Therapeutics logo

Casma Therapeutics

Recent Finacing

Equity

Recent Raise

$7.6M

Casma Therapeutics is a Cambridge, MA biotechnology company developing small-molecule drugs that activate autophagy and lysosomal pathways to treat neurodegenerative and other diseases.

Founded 2017
Massachusetts, United States
11-50
Private
casmatx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Therapeutics

Recent Investors

Third Rock Ventures logo
Eventide Asset Management logo
The Column Group logo
Schroder Adveq logo
E
Eisai logo
Astellas Venture Management logo
Schroders Capital logo
Amgen Ventures logo
Mirae Asset logo
Ono Venture Investment logo
The Michael J. Fox Foundation for Parkinson's Research logo

Financials

$162.1M

Total Raised

4

Funding rounds

11

Investors


Team

Upgrade to view the team

See the team members at Casma Therapeutics.